Document is current
Any future updates will be listed below
-
Authors
Petersen, Tanja Gram https://orcid.org/0000-0003-3509-1953
Rubin, Katrine Hass
Javaid, Muhammad Kassim
Hermann, Anne Pernille
Åkesson, Kristina E.
Abrahamsen, Bo
-
Funding
Funding for this research was provided by:
Interreg (4A JNR 08/4177)
Region Syddanmark (JNR 08/8133)
Odense Universitetshospital (JNR 11/5761)
University of Southern Denmark
- License Information
-
More Information
Article History
Received: 12 November 2024
Accepted: 13 February 2025
First Online: 24 February 2025
Declarations
:
: The study is approved by the Regional Committee on Health Research Ethics for Southern Denmark (jr.nr S-20090127) and Danish Data Protection Agency.
: The Regional Committee on Health Research Ethics approved the data collection for the ROSE trial through questionnaires. Women in the ROSE screening group invited for DXA received both oral and written information before signing informed consent.
: TGP and KHR have no conflict of interest to disclosure. BA has received institutional grants from UCB, Pharmacosmos, and Kuowa-Kirin, consulting fees from UCB and Kuowa-Kirin, and lecture fees from Gedeon-Richter. KEÅ has received lectures without fees from Amgen, UCB, and Honoraria Astellas Pharma. MKJ has received institutional/ personal consulting fees/support from UCB, Amgen, UCB, Abbvie, Besin Healthcare, and Sanofi. APH has received a fee for lectures from UCB, AMGEN, Gideon Richter, a travel grant from UCB, and payment for participation on board from UCB, Gideon Richte.
